Details for New Drug Application (NDA): 076243
✉ Email this page to a colleague
The generic ingredient in LITHIUM CARBONATE is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
Summary for 076243
Tradename: | LITHIUM CARBONATE |
Applicant: | Norvium Bioscience |
Ingredient: | lithium carbonate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 076243
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 300MG | ||||
Approval Date: | Jun 27, 2002 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 150MG | ||||
Approval Date: | Feb 24, 2003 | TE: | RLD: | No |
Complete Access Available with Subscription